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Abstract
Background: The purpose of the present study was to compare dynamic muscle strength, functional performance,
fatigue, and quality of life in premenopausal systemic lupus erythematosus (SLE) patients with low disease activity
versus matched-healthy controls and to determine the association of dynamic muscle strength with fatigue,
functional performance, and quality of life in SLE patients.
Methods: We evaluated premenopausal (18–45 years) SLE patients with low disease activity (Systemic lupus
erythematosus disease activity index [SLEDAI]: mean 1.5 ± 1.2). The control (n = 25) and patient (n = 25) groups
were matched by age, physical characteristics, and the level of physical activities in daily life (International Physical
Activity Questionnaire IPAQ). Both groups had not participated in regular exercise programs for at least six months
prior to the study. Dynamic muscle strength was assessed by one-repetition maximum (1-RM) tests. Functional
performance was assessed by the Timed Up and Go (TUG), in 30-s test a chair stand and arm curl using a 2-kg
dumbbell and balance test, handgrip strength and a sit-and-reach flexibility test. Quality of life (SF-36) and fatigue
were also measured.
Results: The SLE patients showed significantly lower dynamic muscle strength in all exercises (leg press 25.63%, leg
extension 11.19%, leg curl 15.71%, chest press 18.33%, lat pulldown 13.56%, 1-RM total load 18.12%, P < 0.001-0.02)
compared to the controls. The SLE patients also had lower functional performance, greater fatigue and poorer
quality of life. In addition, fatigue, SF-36 and functional performance accounted for 52% of the variance in dynamic
muscle strength in the SLE patients.
Conclusions: Premenopausal SLE patients with low disease activity showed lower dynamic muscle strength, along with
increased fatigue, reduced functional performance, and poorer quality of life when compared to matched controls.
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Background
It has been speculated that fatigue, a symptom fre-
quently observed in approximately 80% of SLE patients
[1], may contribute to a reduction in physical fitness
(i.e., muscle weakness and low cardiovascular capacity),
which, in turn, leads to an impairment in the perform-
ance of activities of daily living and consequently, in the
overall quality of life [2].
Most studies examining the relationship between phys-
ical fitness and overall health in SLE patients have only
addressed cardiovascular fitness [2]. However, decrements
in muscle strength have also been strongly associated with
a greater number of cardiovascular events [3,4] and early
mortality [5,6] in several populations. Currently, the asso-
ciation between dynamic muscle strength, fatigue, func-
tional performance, and quality of life in SLE patients
remains unknown.
Previous studies have demonstrated that SLE patients
have decreased isometric muscle strength when compared
to healthy controls [7,8]. These studies evaluated muscle
strength through isometric tests. Dynamic strength tests
may be more informative than static tests for physical
function evaluation because daily living functioning pri-
marily encompasses dynamic rather than isometric con-
tractions [7,8]. These previous studies also did not control
for important confounding factors that affect physical per-
formance, such as obesity [3], fibromyalgia [9,10], peri-
menopause [11], smoking [12], using beta-blockers [13]
and statins [14], activities of daily living and physical activ-
ity level [15], and socioeconomic status [7]. In the present
study, we did correct for these confounding factors; there-
fore, their influence on the dependent variables may be
considered minimal.
Thus, the objective of this study was twofold: 1) to com-
pare dynamic muscle strength, functional performance, fa-
tigue, and quality of life in premenopausal SLE patients
with low disease activity versus matched-healthy controls
and 2) to determine the association between dynamic
muscle strength and fatigue, functional performance, and
quality of life in these patients. We hypothesised that
premenopausal SLE patients withp low disease activity
would present reduced dynamic muscle strength when
compared with their healthy peers. Furthermore, we
hypothesised that low dynamic muscle strength would be
associated with fatigue, poor functional performance, and
impaired quality of life in SLE patients.
Methods
Study design and patients
The study was conducted between January 2009 and January
2011. A single examiner analysed the medical records and
conducted structured interviews with 240 patients who were
being followed in the outpatient Clinic of Rheumatology at
the Brasilia University Hospital (HUB, Brasilia/Brazil). The
interviews included socioeconomic status (e.g., education,
employment, and income). Disease activity was assessed by
the Systemic Lupus Erythematosus Disease Activity Index
(SLEDAI) [16]. The control group was recruited through
email, leaflets, and posters. Healthy women were primarily
matched by physical activity levels, age and physical charac-
teristics (i.e., body weight and body fat). The participants
provided signed informed consent. The study was approved
by the local ethics committee and was in accordance with
the Helsinki Declaration of 1975, as revised in 1983.
Inclusion criteria
All participants were premenopausal women. The SLE
patients met the American College of Rheumatology
(ACR) criteria [16], with stable disease (i.e., no flare-ups
or changes in medication for at least 3 months before
entering the study) [17]. Additionally, all participants
had not engaged in regular exercise programs for at least
six months prior to the study [10].
Exclusion criteria
The following exclusion criteria were applied: SLEDAI >
5 (n = 19), serum creatinine ≥ 265 mmol/l, myositis, haem-
atocrit ≤ 30%, nephritis and/or leukopenia (n = 13), history
of myocardial infarction, cardiomyopathy, hypertension
and/or the use of beta-blockers (n = 18), type 2 diabetes
mellitus (n = 6), neurological diseases (n = 4),
hypothyroidism (n = 5), fibromyalgia (n = 23), osteopor-
osis (n = 6), rheumatoid arthritis (n = 3), Sjögren’s syn-
drome (n = 2), cancer (n = 1), age < 18 years (n = 2) and >
45 years (n = 39), residence located far (other state) from
the research centre (n = 40), body mass index (BMI) < 18
kg/m2 (n = 1) and > 30 kg/m2 (n = 8), smoking (n = 10),
pregnancy (n = 1), and engaged in regular exercise (n =14).
Methods
The participants who met the inclusion criteria visited
the laboratory on three different occasions in 48 to 72-
hour intervals at the same time (2–4 pm). Two days
prior to the tests, the participants were recommended to
avoid intensive exercise, caffeine or alcohol intake. The
evaluations were not performed during the menstrual
period. On the first day, fatigue symptoms, quality of life,
and physical activity level were assessed [15,18,19]. Add-
itionally, anthropometric measurements and functional
performance tests were performed. The patients were
also familiarised with the one-repetition maximum
strength tests (1-RM). On the second and third days, the
1-RM test and re-test were performed, respectively.
Anthropometric measurements
A single examiner evaluated height, weight, and BMI.
Body fat was estimated using the skinfold measurement,
as previously described [20].
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Fatigue symptoms, quality of life, and physical activity level
All questionnaires were administered prior to the phys-
ical tests. The following fatigue scales were used: Fatigue
Severity Scale (FSS) [1], which consists of a 9-question
questionnaire with a score ranging from 1 to 7. Quality
of life was assessed using the Short-Form Health Survey
36 (SF-36) [19], which consists of 36 items grouped
into eight sub-domains (i.e., physical functioning, role-
physical functioning, bodily pain, general health, vitality,
social functioning, role-emotional functioning, and men-
tal health). The SF-36 score ranges from 0 to 100, with a
higher score indicating better health-related quality of
life. The level of physical activities of daily living was
evaluated using the short version of the International
Physical Activity Questionnaire (s-IPAQ) [18], which
consists of questions regarding the frequency (i.e., days
per week) and duration (i.e., minutes per day) of occupa-
tional and recreational activities of daily living and struc-
tured exercise programs according to the physical
activity level. The subjects were classified into three cat-
egories: active, irregularly active, and inactive.
Functional performance tests
Physical function was assessed through the following
battery of tests. The 30-s chair stand test evaluated the
number of times that a subject was able to stand from a
standard chair and sit down again in 30 seconds [21].
The 30-s arm curl test assessed upper-body muscle func-
tion by the number of arm curl repetitions performed
with 2-kg dumbbell for 30 seconds [21]. The handgrip
strength test (Takei Kiki Kogyo Co., Ltd., Japan) evalu-
ated the maximal isometric strength of the dominant
hand using a calibrated dynamometer. The volunteers
stand erect holding the dynamometer parallel to the
side, with the dial facing away from the body. Each par-
ticipant performed the test twice, with a 1-minute rest
period between the measurements. The best value was
chosen for the analysis. The grip position of the TKK
dynamometer was adjusted to the individual’s hand size
[22]. The Timed Up and Go (TUG) test assessed the
time that a subject required to rise from a standard arm
chair, walk 3 meters away, turn, return, and sit down
again [23]. The one foot balance test with eyes closed
assessed balance by having subject stand on one foot
with eyes closed for up to 30 seconds [24]. The sit and
reach test evaluated flexibility using the modified chair
sit-and-reach test, as previously described [25].
Dynamic muscle strength
The 1-RM test was used to determine the dynamic
muscle strength of the upper- and lower-limbs [26]
using conventional weight machines (Johnson Health
Technologies, Taiwan) [5,27-29]. Prior to the 1-RM test,
two light warm-up sets were performed in two-minute
intervals. Then, the participants were given up to five at-
tempts to achieve the 1-RM load (i.e., the maximum
weight that could be lifted once using proper technique),
with a five-minute interval between the attempts. The 1-
RM tests were conducted for leg press, chest press, leg
extension, lat pulldown, and leg curl exercises. The
strength tests were performed on two different days and
were separated by a 48–72 minute period, which allowed
the calculation of the test-retest reliability (i.e., intra-
class coefficient [ICC]) for both groups [28].
Sample size calculation was cited in a previous study
[30] and assumed an effect size of 0.97 between groups;
thus, a minimum sample of 25 volunteers for each group
was required to provide 90% power (5% significance).
The non-paired Student's T-test or Mann–Whitney U-
test was used to compare the groups. Physical activity
levels and socioeconomic status data were analysed by
Pearson's chi-squared test.
The forward stepwise linear regression model was
used to investigate the relationship between muscle
strength (as the dependent variable) versus functional
performance (i.e., 30-s chair stand test and handgrip
tests), fatigue (i.e., FSS score), and quality of life (phy-
sical functioning subscale from SF-36) for the SLE
patients. The regression model was applied as the 1-
RM-total (muscle strength: sum of total load lifted in
the 1-RM tests [i.e., leg press + leg extension + leg curl +
chest press + lat pulldown]), according to Ruiz et al. [5].
Normally distributed data are expressed as the mean±SD,
and non-normally distributed data are expressed as
median and interquartile range. The significance level
was set at 5%. The analyses were performed using the
software SAS for Windows 9.2 (SAS Institute Inc., Cary,
NC, USA).
Results
Patients
Twenty-five premenopausal SLE patients with a low
disease activity (SLEDAI = 1.5 ± 1.2, range = 0–5, 9 of 25
patients) and a disease duration of 5.3±4.6 years (range =
1–20 years) participated in this study. The patients were
taking corticosteroids (21/25 [84%], dose = 6.07 ±2.1 mg/
day, range = 5–20 mg/day), azathioprine (8 of 25 patients
[32%], dose = 87.50 ±46.8 mg/day, range 50–200 mg/day),
chloroquine diphosphate (17/25 [68%], dose = 205.88 ±
66.4 mg/day), and hydroxychloroquine (2 of 25 patients
[8%], dose = 400 ±0.0 mg/day). The primary characteris-
tics of the SLE patients and the matched healthy controls
are shown in Table 1.
Socioeconomic status
The SLE patients had lower educational level than the
controls, P < 0.05). The groups did not differ regarding
other socioeconomic status variables (P > 0.05) (Table 2).
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s-IPAQ
None of the participants had engaged in regular exercise
programs for at least six months prior to the study. The
level of physical activities of daily living was similar be-
tween the groups (P = 0.12). In the SLE group, 17 of 25
(68%) patients were active, 3 of 25 (12%) were irregularly
active, and 5 of 25 (20%) were inactive. In the control
group, 23 of 25 (92%) subjects were active, 1 of 25 (4%)
was irregularly active, and 1 of 25 (4%) was inactive.
Fatigue symptom and quality of life
When compared with the controls, the SLE patients had
significantly higher FSS score (P < 0.01). The SLE pa-
tients also had poorer quality of life parameters when
compared with the controls, (all P < 0.05), except for vi-
tality and bodily pain domains (both P > 0.05) (Table 3).
Functional performance
When compared with the controls, the SLE patients had
a significantly lower functional performance in general
(handgrip test = −10.35%, TUG test = − 5.94%, 30-s
chair timed-stand test = − 18.60%, 30-s arm curl test =
− 16.58%, all P < 0.05), except for balance and flexibility
(both P > 0.05) (Table 3).
Muscle strength (1-RM)
The ICC for the 1-RM test was 0.98 (CI 0.60, 0.99) and
0.99 (CI 0.86, 0.98) for the SLE and control groups, re-
spectively. The SLE patients had a significantly lower
1-RM than the controls in all exercises (1-RM =
−25.63%, leg extension = −11.19%, leg curl = −15.71%,
chest press = −18.33%, lat pulldown = −13.56%, 1-RM
[total load] = − 18.12%, 1-RM/relative [total load/body
weight = − 17%, all P < 0.05]) (Table 4).
Linear regression model
The final model for dynamic muscle strength, which
included the functional performance tests (handgrip
and timed chair stands), SF-36 (physical role func-
tioning and emotional role functioning scores), and
FSS scores, accounted for 52% of the variance in dy-
namic muscle strength (F= 5.62, P = 0.02, VIF < 10,
Table 5). Unexpectedly, physical role functioning was
Table 1 Main characteristics of SLE patients versus matched-healthy controls
Variable SLE CONTROLS Difference between means P-value
(n = 25) (n = 25) (95% CI)#
Age, years, median (IQR)† 29.9 (6.8) 29.2 (8.1) 0.7671
Body mass, kg 57.7 ± 6.7 58.3 ± 8.2 0.69 (−3.6, 4.9) 0.7462
Height, cm 158.1 ± 0.1 158.3 ± 0.9 −0.01 (−0.1, 0.1) 0.6573
Lean body mass, kg 38.1 ± 4.8 38.5 ± 3.8 0.5 (−2.1, 2.9) 0.6966
BMI, kg/height2 23.1 ± 2.9 23.5 ± 3.3 0.5 (−13, 2.2) 0.5998
Body fat, % 33.5 ± 9.2 33.2 ± 8.6 −0.3 (−5.4, 4.7) 0.8997
Sum of skinfolds, mm 79.8 ± 19.4 79.6 ± 18.4 −0.1 (−10.9, 10.6) 0.9769
Thigh skinfold, mm 23.1 ± 5.6 22.3 ± 6.4 −0.8 (−4.2, 2.6) 0.6351
Right thigh circumference, cm 55.2 ± 4.2 56.2 ± 3.6 1.1 (−1.2, 3.3) 0.3404
Systolic blood pressure, mmHg 108.0 ± 10.2 106 ± 8.6 −2.3 (−7.7, 3.1) 0.3818
Diastolic blood pressure, mmHg, median (IQR)† 68.0 (11.4) 69.0 (9.8) 0.7410
Heart rate, bpm 80.0 ± 10.3 81.0 ± 14.9 1.2 (−6.1, 8.5) 0.7432
* Values are expressed as the mean ± SD unless otherwise stated. † These variables are not normally distributed and therefore, are expressed as median.
# Calculated only when Student’s t-test was used. SLE systemic lupus erythematosus, CI confidence interval, IQR interquartile range, BMI body mass index, mmHg
millimetres of Mercury, BPM beats per minute.
Table 2 Socioeconomic characteristics of the SLE patients
and healthy controls
Variable Group
SLE CONTROLS P-value
N % N %
Educational level
Literacy, 0 to 4 years 3 12 0 0 0.0003
Primary, 5 to 8 years 8 32 0 0
Secondary, 9 to 12 years 9 36 23 92
University, 12 years > 5 20 2 8
Employment
Paid 14 56 19 76 0.0702
Unemployed 11 44 6 24
Income†
No income 10 40 6 24 0.5345
Up to 1 minimum salary 6 24 8 32
From 1 to 2 minimum salaries 6 24 8 32
Over 2 minimum salaries 3 12 3 12
† Brazilian minimum salary equivalent to US$280.00 in 2009 (R$ 465.00).
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inversely related to 1-RM in the final model. How-
ever, physical role functioning seemed to be a weak
independent factor in 1-RM change (R2 = 0.14; =
−0.38), therefore the role of this variable as a
predictor in the final model must be interpreted with
caution. The errors in the model were inde-
pendently distributed (Durbin-Watson = 2.19), and
multicollinearity was not detected (VIF = 1.0).
Adverse events
No adverse events were recorded during the experimen-
tal period. Additionally, none of the patients reported
joint pain at time of testing.
Discussion
The novel finding of this study is that premenopausal
SLE patients with low disease activity show lower
Table 3 Functional capacity, fatigue scores and quality of life in the SLE patients and controls*
Variable SLE CONTROLS Difference between means P-value
(n = 25) (n = 25) (95% CI)#
Functional performance
Handgrip strength, kg 24.2 ± 4.9 27.1 ± 4.7 2.8 (0.1; 5.5) 0.0464
30-s chair stand test, repetitions 19.6 ± 5.6 24.1 ± 3.7 4.5(1.7; 7.2) 0.0018
30-s arm curl test, repetitions 20.5 ± 3.3 24.6 ± 3.6 4.1 (2.1; 6.1) 0.0001
Timed Up and Go, s 5.3 ± 0.4 5.0 ± 0.6 −0.3 (−0.6; −0.0) 0.0495
Flexibility sit and reach, cm 24.0 ± 9.5 29.0 ± 9.4 5.0 (−0.40; 10.4) 0.0680
30-s balance, s 17.6 (9.8) 17.0 (9.1) - 0.7848
Fatigue symptom
FSS, median (IQR)† 3.5 (1.2) 2.5 (0.9) - 0.0043
Quality of life, SF-36
Physical functioning, median (IQR)† 61.6 (24.4) 81.2 (14.5) - 0.0029
Role-physical functioning, median (IQR)† 53.0 (41.03) 78.0 (25.3) - 0.0375
Bodily pain, median (IQR)† 64.4 (25.7) 72.9 (22.0) - 0.2752
General health 51.1 ± 17.8 67.4 ± 16.3 16.3 (6.6; 26.0) 0.0014
Vitality, median (IQR)† 54.8 (11.5) 55.2 (10.3) - 0.9686
Social functioning, median (IQR)† 68.4 (24.0) 83.8 (18.3) - 0.0266
Role-emotional functioning 41.1 (39.9) 73.2 (36.1) - 0.0073
Mental health, median (IQR)† 50.0 (13.2) 58.5 (10.6) 8.5 (1.7; 15.3) 0.0150
* Values expressed as the mean ± SD, unless otherwise stated. † These variables are not normally distributed and therefore are expressed as median. # Calculated
only when Student’s t-test was used. SLE systemic lupus erythematosus, CI confidence interval, FSS fatigue severity scale, IQR interquartile range.
Table 4 Dynamic muscle strength (1-RM) in SLE patients and controls*
Variable (1-RM) SLE CONTROLS Difference between means P-value
(n = 25) (n = 25) (95% CI)#
Leg press, kg 71.1 ± 18.6 95.6 ± 19.7 24.5 (13.6; 35.5) < 0.0001
Leg extension, kg 64.7 ± 10.6 72.9 ± 13.9 8.1 (1.1; 15.2) 0.0242
Leg curl, kg 30.2 ± 5.2 35.8 ± 6.9 5.6 (2.1; 9.1) 0.0022
Chest press, kg 34.7 ± 7.2 43.1 ± 7.9 8.4 (4.1; 12.7) 0.0002
Lat pulldown, kg 36.2 ± 6.4 41.8 ± 5.8 5.6 (2.2; 9.1) 0.0019
1-RM-total, kg 47.4 ± 8.1 57.8 ± 8.7 10.4 (5.7; 15.0) < 0.0001
1-RM-total, kg/kg of body weight 0.8 ± 0.1 1.0 ± 0.1 0.2 (0.1; 0.2) < 0.0001
* These values are expressed as the mean SD unless otherwise stated. † These variables are not normally distributed and therefore, are expressed as median. #
Calculated only when Student’s t-test was used. SLE = systemic lupus erythematosus; CI = confidence interval of 95%; 1-RM = 1-RM consists of performing a full
range of motion with the greatest possible load; 1-RM -total = sum of total load lifted in the 1-RM tests (i.e., leg press, leg extension, leg curl, chest press, and lat
pulldown); 1-RM-total, kg/kg of body weight = median of the sum of the load of the 1-RM tests in leg press, leg extension, leg curl, chest press, and lat pulldown
divided by body weight.
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dynamic muscle strength (upper- and lower-limb) when
compared with their healthy peers. Furthermore, we pro-
vided the evidence that lower dynamic muscle strength
was associated with fatigue, low functional performance,
and poor quality of life (namely, role-emotional function-
ing) in SLE patients.
Our results are in agreement with those by Tench et al.
[7] and Stockton et al. [8], who demonstrated that SLE pa-
tients have lower isometric muscle strength when com-
pared with healthy controls. However, the aforementioned
studies evaluated muscle strength using isometric tests. In
this regard, one may argue that dynamic strength tests
may be more informative than static tests in terms of
physical function evaluation because daily living function-
ing primarily encompasses dynamic rather than isometric
contractions [7]. In fact, the significant association be-
tween dynamic strength (i.e., 1-RM) and physical function
assessments (i.e., chair timed-stands) observed in the
current study further supports this notion.
Fatigue scores (as assessed by the FSS questionnaire)
lower than 4.0 suggest that fatigue is not severe enough
to limit participation in daily living physical activities.
Conversely, FSS scores higher than 4.0 suggest that fa-
tigue is perceived to adversely affect the ability to engage
in physical and social activities [1]. In the current study,
however, the SLE patients scored 3.5 on average (with 15
of 25 patients having FSS scores lower than 4). However,
the patients experienced decreased physical function,
low dynamic muscle strength capacity, and poor quality
of life, suggesting that either “residual” fatigue or other
factors (e.g., long-term medication or systemic inflam-
mation) may have contributed to the poor health-related
findings demonstrated in this study. Further studies
must elucidate the role of fatigue on health-related pa-
rameters in SLE patients.
We observed that even with low fatigue and low dis-
ease activity scores, 20% (5 of 25) of the SLE patients
showed handgrip strength between 17 and 20 kg. Notably,
these values are considered a marker of sarcopenia [23].
The handgrip strength test has been considered a clinical
marker of mobility [23,31] and lower limb muscle strength
[23]. Moreover, a 5-kg increase in handgrip strength has
been associated with a significantly reduced mortality risk
[6]. This fact, along with the fact that the handgrip
strength test has been proven reliable in SLE patients [32],
make this simple and inexpensive tool an emerging
marker of clinical relevance. Further prospective studies
should test its ability as a prognostic marker in SLE.
Our study must be interpreted in light of its strengths
and limitations. Although a few studies have also demon-
strated lower physical function in SLE patients [7,8], these
studies did not control for important confounding factors
that affect physical performance, such as obesity [3], fibro-
myalgia [9,10], perimenopause [11], smoking [12], use of
beta-blocker [13] and statins [14], activities of daily living,
physical activity level [15], and socioeconomic-status [7].
In the present study, we did correct for these confounding
factors; therefore, their influence on the muscle strength
may be considered minimal.
However, this study is not without limitations. First,
the cross-sectional nature of this study precluded us to
establish cause-effect relationships between muscle
strength and health-related parameters in SLE patients
(e.g., role-emotional functioning from SF-36). Second,
our homogeneous sample comprised premenopausal
SLE patients with low disease activity and who were
free of comorbidities and associated diseases. There-
fore, one cannot extrapolate the present results to older
or younger patients with more severe disease. Finally,
our sample size was relatively low. Further studies
should test the accuracy of our multivariate model in a
larger patient cohort.
Conclusions
In conclusion, the current study provided novel evidence
that lower- and upper-body dynamic muscle strength is
reduced in premenopausal SLE patients with low disease
activity when compared with their controls. Importantly,
we also demonstrated that lower dynamic muscle strength
is associated with fatigue, low functional performance, and
poor quality of life in SLE patients.
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Table 5 Association between dynamic muscle strength and functional performance tests, SF-36 subscale and fatigue score
Dependent variable Independent variable β^ Standard error R2 P-value
1-RM-total, kg Role-physical functioning (SF-36) -0.38 0.09 0.14 < 0.001
Handgrip test 2.09 0.61 0.22 0.0027
Role-emotional functioning (SF-36) 0.23 0.08 0.34 0.0125
Timed chair-stand test 1.61 0.53 0.42 0.0065
Fatigue (FSS) -9.80 4.13 0.52 0.0218
β^ = parameter estimate, R2 = coefficient of determination; 1-RM = one repetition maximum is the largest possible load of a particular movement; 1-RM -total =
sum of total load lifted in the 1-RM tests (i.e., leg press, leg extension, leg curl, chest press, and lat pulldown); SF-36 self-administered health questionnaire - Short
Form Health Survey 36, FSS fatigue severity scale.
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